Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Cell & Gene Therapy
Biotech
Otsuka gives cancer candidates the kiss-off on strategic grounds
The Japanese drugmaker said strategic reasons—the pharma equivalent of “it’s not you, it’s me”—underpinned the decision to ax the assets.
Nick Paul Taylor
Feb 14, 2025 5:30am
Encoded lays off 29% of staff to fund Dravet gene therapy trial
Feb 13, 2025 10:20am
Galapagos drops one CD19 CAR-T to focus on 'flagship' program
Feb 13, 2025 8:00am
Voyager's ALS program delayed by search for alternative payload
Feb 11, 2025 10:27am
Turnstone ends final TIL program over costs, plots more layoffs
Feb 4, 2025 10:30am
Kadimastem gets shareholder backing for NLS merger
Jan 31, 2025 9:42am
More News
Judge rules against investor trying to block Aurion IPO
Jan 28, 2025 2:54pm
Cell therapy biotech Aurion joins IPO surge
Jan 27, 2025 2:42pm
Notch begins 'significant' layoffs, blames tough environment
Jan 17, 2025 6:30am
Umoja secures $100M series C to bring more CAR-Ts into clinic
Jan 14, 2025 8:50am
See more stories